Evidence map›Paper›PMID 33626237›Full record

ArticleAnnals of clinical and translational neurology2021

Leveraging electronic health records data to predict multiple sclerosis disease activity.

Yuri Ahuja, Nicole Kim, Liang Liang, Tianrun Cai, Kumar Dahal, Thany Seyok, Chen Lin, Sean Finan, Katherine Liao, Guergana Savovoa and 3 more

Abstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Clustering Sequence Data with Mixture Markov Chains with Covariates Using Multiple Simplex Constrained Optimization Routine (MSiCOR).Journal of computational and graphical statistics : a joint publication of American Statistical Association, Institute of Mathematical Statistics, Interface Foundation of North America · 2024
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Multiple sclerosis relapse risk factors across treatment eras.Multiple sclerosis journal - experimental, translational and clinical
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yuri Ahuja *Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
Nicole Kim *Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
Liang LiangDepartment of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
Tianrun CaiDivision of Rheumatology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Kumar DahalDivision of Rheumatology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Thany SeyokDivision of Rheumatology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Chen LinClinical Natural Language Processing Program, Boston Children's Hospital, Boston, MA, USA.
Sean FinanClinical Natural Language Processing Program, Boston Children's Hospital, Boston, MA, USA.
Katherine LiaoDivision of Rheumatology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Guergana SavovoaClinical Natural Language Processing Program, Boston Children's Hospital, Boston, MA, USA.
Tanuja ChitnisDepartment of Neurology, Brigham and Women's Hospital, Boston, MA, USA.ORCID 0000-0002-9897-4422
Tianxi Cai *Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
Zongqi Xia *Department of Neurology and Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA.ORCID 0000-0003-1500-2589

Funding

VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYticsP30AR072577 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Daniel Hal Solomon · 2017 to 2026
$9.8M
Temporal relation discovery for clinical textR01LM010090 · NLM · BOSTON CHILDREN'S HOSPITAL · PI MARTIN, JAMES H., SAVOVA, GUERGANA K. · 2010 to 2022
$7.1M
Leveraging electronic health records to optimize treatment selection and response in multiple sclerosisR01NS098023 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Zongqi Xia · 2016 to 2026
$4.6M
Training in Orthopaedic and Musculoskeletal Clinical ResearchT32AR055885 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI KATZ, JEFFREY NEIL, LOSINA, ELENA · 2008 to 2023
$4.0M
NIAMS NIH HHS P30 AR072577NIAMS NIH HHS T32 AR055885NINDS NIH HHS R01 NS098023NLM NIH HHS R01 LM010090
6 · The paper itself

Abstract

objectiveNo relapse risk prediction tool is currently available to guide treatment selection for multiple sclerosis (MS). Leveraging electronic health record (EHR) data readily available at the point of care, we developed a clinical tool for predicting MS relapse risk.

methodsUsing data from a clinic-based research registry and linked EHR system between 2006 and 2016, we developed models predicting relapse events from the registry in a training set (n = 1435) and tested the model performance in an independent validation set of MS patients (n = 186). This iterative process identified prior 1-year relapse history as a key predictor of future relapse but ascertaining relapse history through the labor-intensive chart review is impractical. We pursued two-stage algorithm development: (1) L

resultsThe final model, comprising age, disease duration, and imputed prior 1-year relapse history, achieved a predictive AUC and F score of 0.707 and 0.307, respectively. The performance was significantly better than the baseline model (age, sex, race/ethnicity, and disease duration) and noninferior to a model containing actual prior 1-year relapse history. The predicted risk probability declined with disease duration and age.

conclusionOur novel machine-learning algorithm predicts 1-year MS relapse with accuracy comparable to other clinical prediction tools and has applicability at the point of care. This EHR-based two-stage approach of outcome prediction may have application to neurological disease beyond MS.

Indexed as

Electronic Health RecordsMachine LearningRegistriesAdultDisease ProgressionFemaleHumansLongitudinal StudiesMaleMiddle AgedMultiple SclerosisPrognosisRecurrence

Identifiers

PMID33626237
PMCPMC8045951

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.